Phaarmasia Ltd (NSE: PHRMASI), ISIN INE486I01016 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
PHRMASI last traded at ₹89.25 (-4.03%), with a 52-week range of ₹26.00 to ₹131.75 (as of 30 Jul 2026).
Shareholding as of Dec 2025: promoters 73.51%, FIIs 0.00%, DIIs 0.05%, mutual funds 0.00%.
EquiSense Score (ECS): 30/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.